On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Novartis (United States)

InstitutionResearch output, impact & collaborations

Novartis (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Novartis (United States)?

ScholarIQrecord summary

Novartis (United States) is a research organisation in New York, US. OpenAlex records 12,462 works and 1,792,652 citations for it. 2,896 researchers list it as their most recent affiliation.

How many works does Novartis (United States) have?

ScholarIQindexed works

Novartis (United States) has 12,462 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Novartis (United States) have?

ScholarIQcitation count

Novartis (United States) has 1,792,652 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Novartis (United States)?

ScholarIQresearcher count

Novartis (United States) has 2,896 researchers in the ScholarIQ index.

What is the average h-index at Novartis (United States)?

ScholarIQavg h-index

Novartis (United States) has an average h-index of 37.1 in OpenAlex.

What is the ROR of Novartis (United States)?

ScholarIQror

The ROR for Novartis (United States) is on the source record.

What is the OpenAlex record for Novartis (United States)?

ScholarIQopenalex

The OpenAlex for Novartis (United States) is on the source record.

Who are the most-cited researchers behind Novartis (United States)?

ScholarIQtop researchers by citations
1
Eleftheria Maratos–Flier · Regulation of Appetite and Obesity
149 works27,657 citations
2
Martin Lefkowitz · Heart Failure Treatment and Management
236 works24,682 citations
3
Jill Cheng · Genomics and Chromatin Dynamics
23 works21,515 citations
4
Tom Thurén · Inflammasome and immune disorders
77 works21,075 citations
5
Ronald J. Portman · Blood Pressure and Hypertension Studies
133 works20,185 citations

What are the most-cited papers on Novartis (United States)?

ScholarIQmost cited works
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Paul M. Ridker, Brendan M. Everett, Tom Thurén, Jean MacFadyen, William H. Chang, Christie M. Ballantyne, Francisco Antônio Helfenstein Fonseca, José Carlos Nicolau, Wolfgang Köenig, Stefan D. Anker, John J.P. Kastelein, Jan H. Cornel, Prem Pais, Daniel Pella, Jacques Genest, Renata Cífková, Alberto Lorenzatti, Tamás Forster, Zhanna Kobalava, L Vida-Simiti, Marcus Flather, Hiroaki Shimokawa, Hisao Ogawa, Mikael Dellborg, Paulo R.F. Rossi, Roland P.T. Troquay, Peter Libby, Robert J. Glynn
New England Journal of Medicine. 20179,298 CitationsOPEN ACCESS
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina, Giordano Caponigro, Nicolas Stransky, K. Venkatesan, Adam A. Margolin, Sung Joon Kim, Christopher J. Wilson, Joseph Lehár, Gregory V. Kryukov, Dmitriy Sonkin, Anupama Reddy, Manway Liu, Lauren Murray, Michael F. Berger, John E. Monahan, Paula Morais, Jodi Meltzer, Adam Korejwa, Judit Jané‐Valbuena, Felipa Mapa, Joseph Thibault, Eva Bric-Furlong, Pichai Raman, Aaron Shipway, Ingo H. Engels, Jill Cheng, Guoying Karen Yu, Jianjun Yu, Peter Aspesi, Melanie de Silva, Kalpana Jagtap, Michael D. Jones, Li Wang, Charlie Hatton, Emanuele Palescandolo, Supriya Gupta, Scott Mahan, Carrie Sougnez, Robert C. Onofrio, Ted Liefeld, Laura E. MacConaill, Wendy Winckler, Michael Reich, Nanxin Li, Jill P. Mesirov, Stacey Gabriel, Gad Getz, Kristin Ardlie, Vivien W. Chan, Vic E. Myer, Barbara L. Weber, Jeff Porter, Markus Warmuth, Peter M. Finan, Jennifer L. Harris, Matthew Meyerson, Todd R. Golub, Michael Morrissey, William R. Sellers, Robert Schlegel, Levi A. Garraway
Nature. 20128,591 Citations
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
John J.V. McMurray, Milton Packer, Akshay S. Desai, Jianjian Gong, Martin Lefkowitz, Adel R. Rizkala, Jean L. Rouleau, Victor Shi, Scott D. Solomon, Karl Swedberg, Michael R. Zile
New England Journal of Medicine. 20146,901 CitationsOPEN ACCESS
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
Scott D. Solomon, John J.V. McMurray, Inder S. Anand, Junbo Ge, Carolyn S.P. Lam, Aldo P. Maggioni, Felipe A. Martínez, Milton Packer, Marc A. Pfeffer, Burkert Pieske, Margaret M. Redfield, Jean L. Rouleau, Dirk J. van Veldhuisen, Faı̈ez Zannad, Michael R. Zile, Akshay S. Desai, Brian Claggett, Pardeep S. Jhund, S. А. Boytsov, Josep Comín‐Colet, John G.F. Cleland, Hans‐Dirk Düngen, Eva Gonçalvesová, Tzvetana Katova, Jose F. Kerr Saraiva, Małgorzata Lelonek, Béla Merkely, Michele Senni, Sanjiv J. Shah, Jingmin Zhou, Adel R. Rizkala, Jianjian Gong, Victor Shi, Martin Lefkowitz
New England Journal of Medicine. 20192,383 CitationsOPEN ACCESS
Building Memories: Remembering and Forgetting of Verbal Experiences as Predicted by Brain Activity
Anthony D. Wagner, Daniel L. Schacter, Michael Rotte, Wilma Koutstaal, Anat Maril, Anders M. Dale, Bruce R. Rosen, Randy L. Buckner
Science. 19981,660 Citations

How much of the research on Novartis (United States) is open access?

ScholarIQopen access share
67%OPEN ACCESS
Gold
0%
Green
0%
Hybrid
8%
Bronze
58%
Closed
33%

Related on ScholarIQ

470M+ articles · 14-day free trial